IFNA12P: A Promising Drug Target and Biomarker for Interferon Alpha 12

Target Name: IFNA12P

NCBI ID: G158011

IFNA12P

Other Name(s): interferon alpha 12, pseudogene | IFNP12 | Interferon, alpha 12, pseudogene | IFNWP12

IFNA12P: A Promising Drug Target and Biomarker for Interferon Alpha 12

Abstract:

Interferon alpha 12 (IFNA12) is a cytokine that plays a crucial role in the regulation of immune and inflammatory responses. The IFNA12 gene has been pseudogenized, and its encoded protein has been shown to have potential as a drug target or biomarker. In this article, we will discuss the IFNA12 protein, its functions, potential drug targets, and its potential as a biomarker for various diseases.

Introduction:

IFNA12 is a cytokine that is expressed in various tissues and cells of the body. It is a key regulator of the immune response, and its levels are closely monitored by the body. IFNA12 is composed of two isoforms, IFNA12p and IFNA12q, which differ in their cytoplasmic localization. IFNA12p is predominantly cytoplasmic, whereas IFNA12q is predominantly nuclear.

IFNA12p has been shown to play a crucial role in the regulation of cellular processes, including cell adhesion, migration, and apoptosis. It is also involved in the regulation of inflammation and immune responses. IFNA12p has been shown to promote the survival of cancer cells and to inhibit the death of cancer cells that have been treated with chemotherapy.

Potential Drug Targets:

IFNA12p is a potential drug target for various diseases, including cancer, autoimmune diseases, and neurodegenerative diseases. One of the main drug targets for IFNA12p is the inhibition of its activity, as this can lead to the downregulation of IFNA12p and the regulation of cellular processes.

IFNA12p has been shown to interact with several protein partners, including the transcription factor NF-kappa-B and the protein heat shock factor HSP70. These interactions may play a role in the regulation of cellular processes and the development of diseases.

IFNA12p has also been shown to interact with several small molecules, including inhibitors of the protein kinase Akt and the tyrosine kinase TYK. These interactions may also play a role in the regulation of cellular processes and the development of diseases.

Biomarkers:

IFNA12p has the potential to serve as a biomarker for various diseases. One of the main applications of IFNA12p as a biomarker is its ability to be used as a marker for cancer. IFNA12p has been shown to be overexpressed in various types of cancer, including breast, lung, and colorectal cancer. This overexpression may serve as a potential biomarker for cancer.

IFNA12p has also been shown to be involved in the regulation of inflammation and immune responses. This may make it a potential biomarker for autoimmune diseases, such as rheumatoid arthritis and inflammatory bowel disease.

IFNA12p has also been shown to play a role in the regulation of cellular processes, including cell adhesion and migration. This may make it a potential biomarker for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

Conclusion:

IFNA12p is a cytokine that plays a crucial role in the regulation of immune and inflammatory responses. Its pseudogene has been shown to have potential as a drug target or biomarker for various diseases, including cancer, autoimmune diseases, and neurodegenerative diseases. Further research is needed to fully understand the functions of IFNA12p and its potential as a drug

Protein Name: Interferon Alpha 12, Pseudogene

The "IFNA12P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IFNA12P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets